Navigating regulatory pathways for translation of biologic cartilage repair products

Abstract excerpt

Long-term clinical repair of articular cartilage remains elusive despite advances in cartilage tissue engineering. Only one cartilage repair therapy classified as a "cellular and gene therapy product" has obtained Food and Drug Administration (FDA) approval within the past decade although more than 200 large animal cartilage repair studies were published. Here, we identify the challenges impeding translation of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Knee injuries and reconstruction techniques
• Share to Osteoarthritis Treatment and Mechanisms